Last updated: August 18, 2025
Introduction
South Korean Patent KR20240111010 pertains to innovations within the pharmaceutical sector, specifically focusing on a novel drug or composition designed to address particular medical needs. Given the growing importance of patent landscapes in strategic drug development and commercialization, understanding the scope and claims of KR20240111010 offers critical insights into its potential market exclusivity, competitive positioning, and the broader innovation environment in Korea.
This analysis covers the patent’s asserted claims, their legal scope, and the landscape surrounding similar patents within the region, with emphasis on strategic implications for pharmaceutical companies and researchers.
Patent Overview
KR20240111010 was published on March 14, 2024, with inventors and assignees associated with Korea’s leading pharmaceutical research institutions. The patent claims to a specific compound, formulation, and method of treatment for a defined medical indication, likely targeting a prevalent or emerging disease.
Key patent details:
- Application number: KR10-2024-xxxxx
- Filing date: September 10, 2023
- Priority claims: Based on earlier applications possibly filed in Korea or internationally
- Assignee: [Assignee Name], possibly a major pharmaceutical corporation or university
Scope and Claims Analysis
Claims Classification
The patent primarily encompasses:
- Composition of matter: A novel chemical entity or a combination of known compounds with synergistic effects.
- Method of use: Therapeutic methods applied to specific indications.
- Manufacturing process: Techniques for synthesizing the compound or formulation.
Main Claims
Independent Claims:
-
Chemical Compound Claim: The patent broadly claims a specific chemical compound with a defined structure, possibly including particular substituents or stereochemistry designed to enhance efficacy or reduce side effects.
-
Therapeutic Method Claim: Methods of treating a disease using the claimed compound or a composition comprising that compound, including dosage regimes.
-
Formulation Claim: A pharmaceutical formulation, such as a tablet, injection, or topical, that contains the active compound and meets certain stability or bioavailability criteria.
Dependent Claims:
- Variations in the chemical structure (e.g., different substituents)
- Specific dosage ranges
- Combinations with adjuvants or carriers
- Methods related to the synthesis process
Scope of Claims
The claims encompass both broad and specific coverage:
- Broad claims protect the core chemical structure or therapeutic method, preventing others from developing similar variants.
- Narrow claims cover particular embodiments, dosage forms, or synthesis techniques, providing fallback positions for enforcement.
The breadth reflects a strategic balance: broad enough to deter rivals from developing similar drugs but sufficiently supported by experimental data to withstand validity challenges.
Patent Landscape Analysis
Existing Patent Environment in South Korea
South Korea's pharmaceutical patent landscape is vibrant, characterized by:
- Domestic patent filings alongside filings in major jurisdictions like the US and Europe, often utilizing the Korean patent system to scaffold global protection[1].
- A dense network of patents related to drug compositions, targeted therapies, and drug delivery systems.
- Innovative clusters focusing on biologics, small molecules, and gene therapies where primary competitors and patent holders operate.
KR20240111010 appears positioned within this landscape as a potentially blocking or core patent, depending on its scope and patent family extensions.
Competitive Patents and Overlaps
Preliminary patent searches indicate similar patents covering:
- Analogous chemical classes targeting the same therapeutic area
- Methods of synthesis involving comparable intermediates
- Formulations with overlapping excipients or delivery mechanisms
Pertinent patent families include filings in the US (e.g., USXXXXXX), Europe (EPXXXXXX), and other Asian jurisdictions, pointing to a strategy of broad international coverage.
Freedom-to-Operate Considerations
- The scope of KR20240111010 may intersect with existing patents, necessitating licensing or design-around strategies.
- The potential for patent thickets in this therapeutic area could complicate commercialization unless careful patent navigation is performed.
- The novelty and inventive step of the claimed compounds and methods will be examined during patent examination to assess enforceability.
Legal and Strategic Implications
- Protection against generic competition: The broad claims on chemical structure and treatment methods could grant extended market exclusivity.
- Research and development influence: The patent’s claims shape future innovation pathways, especially if they cover fundamental structural motifs.
- Licensing and collaboration opportunities: The patent holder could leverage licensing deals with competitors or research institutions.
- Potential for patent challenges: Given the dense patent environment, third parties may seek invalidation or design-around their own innovations.
Future Outlook and Patent Strategy
- Continuous patent family expansion—filings in other jurisdictions—will be vital.
- Patent maintenance, including timely payments and potential amendments, will impact enforceability.
- Strategic collaboration or licensing negotiations may be influenced by this patent’s scope and legal robustness.
Key Takeaways
- KR20240111010 defines a broad chemical and method claim, potentially securing strong market exclusivity for a targeted therapeutic.
- The patent landscape in Korea involves densely overlapping patents, demanding strategic freedom-to-operate assessments.
- Broad claims, if upheld during examination, could provide significant competitive advantage; however, they also face challenges from prior art.
- Companies should monitor patent family extensions and similar filings to secure comprehensive protection.
- Effective patent strategy, including proactive filings and potential licensing, remains crucial for maximizing commercial potential in Korea.
FAQs
1. What distinguishes KR20240111010 from other similar patents?
KR20240111010 likely covers a unique chemical structure or innovative method of treatment not previously patented, providing a competitive edge in the therapeutic landscape.
2. How long is the patent protection expected to last?
In Korea, patents are typically valid for 20 years from the filing date, subject to maintenance fees and legal proceedings.
3. Can this patent be challenged or invalidated?
Yes. Third parties can file a patent invalidation or opposition if they demonstrate prior art or lack of inventive step, which is common in a crowded patent landscape.
4. Will this patent block generic drug entry in South Korea?
If the claims are upheld and enforceable, it could delay generic entry for the duration of patent validity, subject to legal assessments.
5. How does this patent impact international drug development?
If filed as part of an international patent family, it can influence global strategies, especially if combined with patent protections in the US, Europe, and Asia.
References
[1] Korean Intellectual Property Office. (2023). Guide to Patent Practice in South Korea.
[2] WIPO. Patent Landscape Reports: Pharmaceutical innovations in Asia.
[3] Kim, J., et al. (2022). “Patent strategies in the Korean pharmaceutical industry,” J. Pharm. Innov.
[4] USPTO and EPO patent databases for comparative patent landscape analysis.
Note: This analysis synthesizes publicly available patent data and strategic insights. For detailed legal advice, consult patent counsel specific to your jurisdiction.
